H.R. 6321: Medicare Lung Cancer Biomarker Testing Coverage Act
Mandate Medicare coverage of lung cancer biomarker testing under title XVIII of the Social Security Act.
Key Activities
Introduced November 2025. Would amend title XVIII of the Social Security Act to require Medicare coverage. Patient advocacy support from ACS CAN and LUNGevity. Status: introduced; requires House Energy & Commerce / Senate Finance Committee progression.